Entia Biosciences Inc. (ERGO) Financials Nov 7, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Entia Biosciences Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 67,608 382,051 403,338 369,273 314,746
Cost of Goods Sold (COGS) incl. D&A 226,676 155,702 132,728 107,465 131,123
COGS excluding D&A 224,386 148,146 115,398 85,938 95,133
Depreciation & Amortization Expense 2,290 7,556 17,330 21,527 35,990
Depreciation 2,290 7,012 15,079 16,374 25,327
Amortization of Intangibles - 544 2,251 5,153 10,663
Gross Income (159,068) 226,349 270,610 261,808 183,623
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 284,755 1.24M 1.64M 1.34M 2.87M
Research & Development 0 0 0 58,101 27,804
Other SG&A 284,755 1.24M 1.64M 1.28M 2.84M
Other Operating Expense 487,366 0 0 0 0
Unusual Expense 0 0 106,642 (75,315) 288,454
EBIT after Unusual Expense 0 0 (106,642) 75,315 (288,454)
Non Operating Income/Expense 0 (254) 83,040 0 0
Non-Operating Interest Income 4,900 3,264 192 4,150 9,882
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 500 258,070 338,864 262,929 144,689
Gross Interest Expense 500 258,070 338,864 262,929 144,689
Interest Capitalized 0 0 0 0 0
Pretax Income (926,789) (1.27M) (1.73M) (1.26M) (3.1M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 - - 0 0
Consolidated Net Income (926,789) (1.27M) (1.73M) (1.26M) (3.1M)
Minority Interest Expense 0 0 0 0 0
Net Income (926,789) (1.27M) (1.73M) (1.26M) (3.1M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (926,789) (1.27M) (1.73M) (1.26M) (3.1M)
Preferred Dividends 0 0 0 (21,400) 87,600
Net Income Available to Common (926,789) (1.27M) (1.73M) (1.24M) (3.19M)
EPS (Basic) (0.20) (0.20) (0.28) (0.17) (0.42)
Basic Shares Outstanding 5.12M 5.3M 6.26M 7.3M 7.53M
EPS (Diluted) (0.20) (0.20) (0.28) (0.17) (0.42)
Diluted Shares Outstanding 5.12M 5.3M 6.26M 7.3M 7.53M
EBITDA (928,899) (1M) (1.35M) (1.06M) (2.65M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Entia Biosciences Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 67,608 382,051 403,338 369,273 314,746
Cost of Goods Sold (COGS) incl. D&A 226,676 155,702 132,728 107,465 131,123
COGS excluding D&A 224,386 148,146 115,398 85,938 95,133
Depreciation & Amortization Expense 2,290 7,556 17,330 21,527 35,990
Depreciation 2,290 7,012 15,079 16,374 25,327
Amortization of Intangibles - 544 2,251 5,153 10,663
Gross Income (159,068) 226,349 270,610 261,808 183,623
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 284,755 1.24M 1.64M 1.34M 2.87M
Research & Development 0 0 0 58,101 27,804
Other SG&A 284,755 1.24M 1.64M 1.28M 2.84M
Other Operating Expense 487,366 0 0 0 0
Unusual Expense 0 0 106,642 (75,315) 288,454
EBIT after Unusual Expense 0 0 (106,642) 75,315 (288,454)
Non Operating Income/Expense 0 (254) 83,040 0 0
Non-Operating Interest Income 4,900 3,264 192 4,150 9,882
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 500 258,070 338,864 262,929 144,689
Gross Interest Expense 500 258,070 338,864 262,929 144,689
Interest Capitalized 0 0 0 0 0
Pretax Income (926,789) (1.27M) (1.73M) (1.26M) (3.1M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 - - 0 0
Consolidated Net Income (926,789) (1.27M) (1.73M) (1.26M) (3.1M)
Minority Interest Expense 0 0 0 0 0
Net Income (926,789) (1.27M) (1.73M) (1.26M) (3.1M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (926,789) (1.27M) (1.73M) (1.26M) (3.1M)
Preferred Dividends 0 0 0 (21,400) 87,600
Net Income Available to Common (926,789) (1.27M) (1.73M) (1.24M) (3.19M)
EPS (Basic) (0.20) (0.20) (0.28) (0.17) (0.42)
Basic Shares Outstanding 5.12M 5.3M 6.26M 7.3M 7.53M
EPS (Diluted) (0.20) (0.20) (0.28) (0.17) (0.42)
Diluted Shares Outstanding 5.12M 5.3M 6.26M 7.3M 7.53M
EBITDA (928,899) (1M) (1.35M) (1.06M) (2.65M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
